On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under ...
Biden administration says popular weight loss drugs have been added to Medicare’s list of medications that will be negotiated ...
Pharmaceutical Technology on MSN7h
Ozempic named in latest Medicare price negotiationsThe negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...
Investor's Business Daily on MSN1h
Novo Nordisk Dives After Medicare Targets Ozempic, Wegovy For Price CutsNovo Nordisk stock tumbled Friday after its weight-loss drug Wegovy landed on Medicare's next list of drugs to face price negotiations.
OraSure Technologies CEO Carrie Eglinton Manner said in her presentation that the firm's recent $25 million acquisition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback